AbbVie’s Skyrizi Bests Stelara Head-To-Head In Crohn’s

 
• By Joseph Haas
  
Head to head
AbbVie's Skyrizi prevailed in a head-to-head trial versus Stelara • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D